ABOUT THIS STUDY
- Hospitalized male or female patients greater than or equal to 18 years of age.
- Patients must be a candidate for or have had a laparotomy, or laparoscopy of an intra-abdominal abscess.
- Patients with a complicated intra-abdominal infection such as:
- an intra-abdominal abscess;
- an intra-abdominal abscess (including liver and spleen) that develops in a post-operative patient after receiving > 48 hours and less than or equal to 5 days of a non-study antibiotic. An intra-abdominal culture must be obtained from the infected site.
- appendicitis complicated by perforation (grossly visible) and abscess and/or periappendiceal abscess;
- perforated diverticulitis complicated by abscess formation or fecal contamination;
- complicated cholecystitis with evidence of perforation or empyema;
- perforation of the large or small intestine with abscess, or fecal contamination;
- purulent peritonitis or peritonitis associated with fecal contamination;
- gastric or duodenal ulcer perforation with symptoms lasting at least 24 hours prior to operation;
- traumatic bowel perforation with symptoms lasting at least 12 hours prior to operation.
- Patients with any concomitant condition that, in the opinion of the investigator,
would preclude an evaluation of a response or make it unlikely that the contemplated
course of therapy or follow-up visits could be completed.
- Active or treated leukemia or systemic malignancy that required treatment with
chemotherapy, immunotherapy, radiation therapy or antineoplastic therapy within the
past 3 months, or any metastatic malignancy to the abdomen with life expectancy less
than 6 months.
- Anticipated length of antibiotic therapy less than 5 days.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Multiple Cities,
- Guoxuexiang, Chengdu
- Shengyang, Liaoning
- Hangzhou, Zhejiang